Keros Therapeutics nets $23 mln Series B
Lexington, Massachusetts-based Keros Therapeutics, which is focused on developing treatments for neuromuscular diseases, has raised $23 million in Series B financing. The investors included Pontifax, Arkin Bio Ventures, Partners Innovation Fund, Medison Pharma and Global Health Sciences Fund.
8 January 2019•1 min read
